Australian research shows link between regular aspirin use and age-related macular degeneration.
The Foundation continues its campaign against unfairness in the National Disability Insurance Scheme.
The Foundation welcomes the decision to allow switching of age-related macular degeneration drugs Eylea and Lucentis.
A powerful ‘How’s your macula?’ television advertisement has been produced by the Macular Degeneration Foundation.
There has been a big community response to the Foundation’s campaign to allow AMD drug “switching”.
Macular Degeneration Foundation has announced, as part of World Sight Day activities, the winners of the mEYE World Photographic Competition 2012.
The Macular Degeneration Foundation has launched a new national awareness campaign that featured symptom recognition.
International experts met in Sydney in 2012 to develop a road map for the management of wet age-related macular degeneration.
With a new treatment for wet AMD coming on the market, drug switching between Lucentis and Eylea should be allowed.